1. Home
  2. AXGN
  3. AXGN News

Latest Axogen Inc. (AXGN) News on May 20, 2025

Axogen First Quarter 2025 Earnings: EPS Misses Expectations
AXGN

Simply Wall St.

8 days ago

Axogen First Quarter 2025 Earnings: EPS Misses Expectations

Axogen, Inc.'s (NASDAQ:AXGN) Intrinsic Value Is Potentially 87% Above Its Share Price
AXGN

Simply Wall St.

10 days ago

Axogen, Inc.'s (NASDAQ:AXGN) Intrinsic Value Is Potentially 87% Above Its Share Price

Axogen Inc (AXGN) Q1 2025 Earnings Call Highlights: Revenue Surge and Strategic Progress Amid ...
AXGN

GuruFocus.com

11 days ago

Axogen Inc (AXGN) Q1 2025 Earnings Call Highlights: Revenue Surge and Strategic Progress Amid ...

AxoGen (AXGN) Reports Q1 Loss, Tops Revenue Estimates
AXGN

Zacks

12 days ago

AxoGen (AXGN) Reports Q1 Loss, Tops Revenue Estimates

AXGN

Associated Press Finance

12 days ago

AxoGen: Q1 Earnings Snapshot

Axogen, Inc. Reports 2025 First Quarter Financial Results
AXGN

GlobeNewswire

12 days ago

Axogen, Inc. Reports 2025 First Quarter Financial Results

Axogen Announces Chief Financial Officer Transition
AXGN

GlobeNewswire

12 days ago

Axogen Announces Chief Financial Officer Transition

Axogen, Inc. to report 2025 first quarter financial results on May 8, 2025
AXGN

GlobeNewswire

a month ago

Axogen, Inc. to report 2025 first quarter financial results on May 8, 2025

Stryker Stock Gets Relative Strength Rating Lift
AXGN

Investor's Business Daily

2 months ago

Stryker Stock Gets Relative Strength Rating Lift

Axogen Announces Appointment of Rick Ditto as Vice President, Global Health Economics, Reimbursement & Policy, and Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
AXGN

GlobeNewswire

2 months ago

Axogen Announces Appointment of Rick Ditto as Vice President, Global Health Economics, Reimbursement & Policy, and Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Axogen, Inc. (NASDAQ:AXGN) is a favorite amongst institutional investors who own 75%
AXGN

Simply Wall St.

2 months ago

Axogen, Inc. (NASDAQ:AXGN) is a favorite amongst institutional investors who own 75%

AXGN

MT Newswires

2 months ago

Lake Street Initiates Axogen at Buy With $30 Price Target

Alcon Stock Gets Relative Strength Rating Lift
AXGN

Investor's Business Daily

3 months ago

Alcon Stock Gets Relative Strength Rating Lift

Axogen Inc (AXGN) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic Market ...
AXGN

GuruFocus.com

3 months ago

Axogen Inc (AXGN) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic Market ...

AXGN

Thomson Reuters StreetEvents

3 months ago

Q4 2024 AxoGen Inc Earnings Call

AXGN

Associated Press Finance

3 months ago

AxoGen: Q4 Earnings Snapshot

Axogen, Inc. To Host Analyst & Investor Day on March 4th
AXGN

GlobeNewswire

3 months ago

Axogen, Inc. To Host Analyst & Investor Day on March 4th

Axogen, Inc. Reports 2024 Fourth Quarter and Full-Year Financial Results
AXGN

GlobeNewswire

3 months ago

Axogen, Inc. Reports 2024 Fourth Quarter and Full-Year Financial Results

We Might See A Profit From Axogen, Inc. (NASDAQ:AXGN) Soon
AXGN

Simply Wall St.

3 months ago

We Might See A Profit From Axogen, Inc. (NASDAQ:AXGN) Soon

Axogen, Inc. to report 2024 fourth quarter and full year financial results on February 25, 2025
AXGN

GlobeNewswire

3 months ago

Axogen, Inc. to report 2024 fourth quarter and full year financial results on February 25, 2025

Axogen Announces Appointment of Jesse Bishop as Vice President of Regulatory Affairs and Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
AXGN

GlobeNewswire

4 months ago

Axogen Announces Appointment of Jesse Bishop as Vice President of Regulatory Affairs and Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

AxoGen, Inc. (AXGN) Soars to 52-Week High, Time to Cash Out?
AXGN

Zacks

4 months ago

AxoGen, Inc. (AXGN) Soars to 52-Week High, Time to Cash Out?

AxoGen (AXGN) Moves 18.2% Higher: Will This Strength Last?
AXGN

Zacks

4 months ago

AxoGen (AXGN) Moves 18.2% Higher: Will This Strength Last?

Axogen Announces New VP of Operations and Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
AXGN

GlobeNewswire

4 months ago

Axogen Announces New VP of Operations and Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Axogen Reports Preliminary Unaudited Revenue for Fourth Quarter and Full-Year 2024
AXGN

GlobeNewswire

4 months ago

Axogen Reports Preliminary Unaudited Revenue for Fourth Quarter and Full-Year 2024

AxoGen, Inc. (AXGN) Hits Fresh High: Is There Still Room to Run?
AXGN

Zacks

5 months ago

AxoGen, Inc. (AXGN) Hits Fresh High: Is There Still Room to Run?

Is AxoGen (AXGN) Stock Outpacing Its Medical Peers This Year?
AXGN

Zacks

5 months ago

Is AxoGen (AXGN) Stock Outpacing Its Medical Peers This Year?

Those who invested in Axogen (NASDAQ:AXGN) a year ago are up 98%
AXGN

Simply Wall St.

5 months ago

Those who invested in Axogen (NASDAQ:AXGN) a year ago are up 98%

Are Medical Stocks Lagging Doximity (DOCS) This Year?
AXGN

Zacks

6 months ago

Are Medical Stocks Lagging Doximity (DOCS) This Year?

All You Need to Know About AxoGen (AXGN) Rating Upgrade to Buy
AXGN

Zacks

6 months ago

All You Need to Know About AxoGen (AXGN) Rating Upgrade to Buy

How Much Upside is Left in AxoGen (AXGN)? Wall Street Analysts Think 31.18%
AXGN

Zacks

6 months ago

How Much Upside is Left in AxoGen (AXGN)? Wall Street Analysts Think 31.18%

Axogen Third Quarter 2024 Earnings: Beats Expectations
AXGN

Simply Wall St.

6 months ago

Axogen Third Quarter 2024 Earnings: Beats Expectations

AxoGen Reports Strong Q3 2024 Revenue Growth
AXGN

TipRanks

6 months ago

AxoGen Reports Strong Q3 2024 Revenue Growth

Axogen Inc (AXGN) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic Advancements
AXGN

GuruFocus.com

6 months ago

Axogen Inc (AXGN) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic Advancements

AXGN

Associated Press Finance

6 months ago

AxoGen: Q3 Earnings Snapshot

Axogen, Inc Reports Third Quarter 2024 Financial Results and Provides BLA Update
AXGN

GlobeNewswire

6 months ago

Axogen, Inc Reports Third Quarter 2024 Financial Results and Provides BLA Update

Axogen, Inc. to report third quarter 2024 financial results and host conference call on November 7, 2024
AXGN

GlobeNewswire

7 months ago

Axogen, Inc. to report third quarter 2024 financial results and host conference call on November 7, 2024

AxoGen (AXGN) Surges 8.2%: Is This an Indication of Further Gains?
AXGN

Zacks

7 months ago

AxoGen (AXGN) Surges 8.2%: Is This an Indication of Further Gains?

Axogen Inc (AXGN) Q2 2024 Earnings Call Highlights: Strong Revenue Growth and Raised Guidance ...
AXGN

GuruFocus.com

7 months ago

Axogen Inc (AXGN) Q2 2024 Earnings Call Highlights: Strong Revenue Growth and Raised Guidance ...

Axogen, Inc. (NASDAQ:AXGN) is a favorite amongst institutional investors who own 63%
AXGN

Simply Wall St.

7 months ago

Axogen, Inc. (NASDAQ:AXGN) is a favorite amongst institutional investors who own 63%

Zacks.com featured highlights include Bioventus, Great Lakes Dredge & Dock and AxoGen
AXGN

Zacks

8 months ago

Zacks.com featured highlights include Bioventus, Great Lakes Dredge & Dock and AxoGen

First September Gains in 5 Years? Buy 3 Breakout Stocks Now
AXGN

Zacks

8 months ago

First September Gains in 5 Years? Buy 3 Breakout Stocks Now

Is Aveanna Healthcare (AVAH) Outperforming Other Medical Stocks This Year?
AXGN

Zacks

8 months ago

Is Aveanna Healthcare (AVAH) Outperforming Other Medical Stocks This Year?

Abbott Stock Hurt by Macroeconomic Issues & FX Headwind
AXGN

Zacks

8 months ago

Abbott Stock Hurt by Macroeconomic Issues & FX Headwind

ArrowMark Colorado Holdings LLC Reduces Stake in Axogen Inc
AXGN

GuruFocus.com

8 months ago

ArrowMark Colorado Holdings LLC Reduces Stake in Axogen Inc

AxoGen, Inc. (NASDAQ:AXGN): Are Analysts Optimistic?
AXGN

Simply Wall St.

8 months ago

AxoGen, Inc. (NASDAQ:AXGN): Are Analysts Optimistic?

AXGN

MT Newswires

8 months ago

Axogen Submits Biologics License Application to US FDA for Avance Nerve Graft

Axogen Completes Submission of Biologics License Application to U.S. Food and Drug Administration for Avance Nerve Graft®
AXGN

GlobeNewswire

8 months ago

Axogen Completes Submission of Biologics License Application to U.S. Food and Drug Administration for Avance Nerve Graft®

AxoGen, Inc. (AXGN) Hit a 52 Week High, Can the Run Continue?
AXGN

Zacks

9 months ago

AxoGen, Inc. (AXGN) Hit a 52 Week High, Can the Run Continue?

Axogen Reports Inducement Grant to New Employee Under NASDAQ Listing Rule 5635(C)(4)
AXGN

GlobeNewswire

9 months ago

Axogen Reports Inducement Grant to New Employee Under NASDAQ Listing Rule 5635(C)(4)

What Makes AxoGen (AXGN) a Strong Momentum Stock: Buy Now?
AXGN

Zacks

9 months ago

What Makes AxoGen (AXGN) a Strong Momentum Stock: Buy Now?

Wall Street Analysts See a 25.51% Upside in AxoGen (AXGN): Can the Stock Really Move This High?
AXGN

Zacks

9 months ago

Wall Street Analysts See a 25.51% Upside in AxoGen (AXGN): Can the Stock Really Move This High?

AxoGen, Inc. (AXGN) Hits Fresh High: Is There Still Room to Run?
AXGN

Zacks

9 months ago

AxoGen, Inc. (AXGN) Hits Fresh High: Is There Still Room to Run?

CytoSorbents Appoints Peter J. Mariani Chief Financial Officer
AXGN

GlobeNewswire

9 months ago

CytoSorbents Appoints Peter J. Mariani Chief Financial Officer

AxoGen Second Quarter 2024 Earnings: Beats Expectations
AXGN

Simply Wall St.

9 months ago

AxoGen Second Quarter 2024 Earnings: Beats Expectations

Axogen names ex-Abbott exec Michael Dale as CEO
AXGN

MedTech Dive

9 months ago

Axogen names ex-Abbott exec Michael Dale as CEO

AXGN

MT Newswires

9 months ago

AxoGen Appoints Michael Dale as Chief Executive

AxoGen (AXGN) Q2 Earnings and Revenues Beat Estimates
AXGN

Zacks

9 months ago

AxoGen (AXGN) Q2 Earnings and Revenues Beat Estimates

AXGN

Associated Press Finance

9 months ago

AxoGen: Q2 Earnings Snapshot

Axogen, Inc. Announces New Leadership Appointments
AXGN

GlobeNewswire

9 months ago

Axogen, Inc. Announces New Leadership Appointments

Axogen, Inc. Reports Second Quarter 2024 Financial Results
AXGN

GlobeNewswire

9 months ago

Axogen, Inc. Reports Second Quarter 2024 Financial Results

AxoGen (AXGN) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
AXGN

Zacks

10 months ago

AxoGen (AXGN) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

Axogen, Inc. to Report Second Quarter 2024 Financial Results and Host Conference Call on August 8, 2024
AXGN

GlobeNewswire

10 months ago

Axogen, Inc. to Report Second Quarter 2024 Financial Results and Host Conference Call on August 8, 2024

AxoGen (AXGN) Soars 8.2%: Is Further Upside Left in the Stock?
AXGN

Zacks

10 months ago

AxoGen (AXGN) Soars 8.2%: Is Further Upside Left in the Stock?

Company Reports Inducement Grants to Non-Executive New Employee Under Nasdaq Listing Rule 5635(C)(4)
AXGN

GlobeNewswire

a year ago

Company Reports Inducement Grants to Non-Executive New Employee Under Nasdaq Listing Rule 5635(C)(4)

AXGN

MT Newswires

a year ago

Raymond James Initiates AxoGen at Outperform With $13 Price Target

AxoGen's (AXGN) New Launch to Aid Peripheral Nerve Protection
AXGN

Zacks

a year ago

AxoGen's (AXGN) New Launch to Aid Peripheral Nerve Protection

The past three years for AxoGen (NASDAQ:AXGN) investors has not been profitable
AXGN

Simply Wall St.

a year ago

The past three years for AxoGen (NASDAQ:AXGN) investors has not been profitable

Axogen, Inc Announces Full Launch of Avive+ Soft Tissue Matrix™
AXGN

GlobeNewswire

a year ago

Axogen, Inc Announces Full Launch of Avive+ Soft Tissue Matrix™

Strength Seen in AxoGen (AXGN): Can Its 5.4% Jump Turn into More Strength?
AXGN

Zacks

a year ago

Strength Seen in AxoGen (AXGN): Can Its 5.4% Jump Turn into More Strength?

Axogen Processing Center (APC) Celebrates its Opening with Ohio Leaders in Vandalia
AXGN

GlobeNewswire

a year ago

Axogen Processing Center (APC) Celebrates its Opening with Ohio Leaders in Vandalia

AxoGen (AXGN) Initiates BLA Submission for Avance Nerve Graft
AXGN

Zacks

a year ago

AxoGen (AXGN) Initiates BLA Submission for Avance Nerve Graft

AXGN

MT Newswires

a year ago

AxoGen Initiates Rolling Submission to FDA For Avance Nerve Graft

Axogen Inc. Initiates Rolling Submission of Biologics License Application to U.S. Food and Drug Administration (FDA) for Avance Nerve Graft®
AXGN

GlobeNewswire

a year ago

Axogen Inc. Initiates Rolling Submission of Biologics License Application to U.S. Food and Drug Administration (FDA) for Avance Nerve Graft®

Axogen, Inc to Participate at Leerink Partners Healthcare Crossroads Conference
AXGN

GlobeNewswire

a year ago

Axogen, Inc to Participate at Leerink Partners Healthcare Crossroads Conference

AxoGen, Inc. (NASDAQ:AXGN) Q1 2024 Earnings Call Transcript
AXGN

Insider Monkey

a year ago

AxoGen, Inc. (NASDAQ:AXGN) Q1 2024 Earnings Call Transcript

AxoGen First Quarter 2024 Earnings: Misses Expectations
AXGN

Simply Wall St.

a year ago

AxoGen First Quarter 2024 Earnings: Misses Expectations

AXGN

GuruFocus.com

a year ago

Axogen Inc (AXGN) Q1 2024 Earnings Call Transcript Highlights: Navigating Growth Amidst Challenges

AxoGen (AXGN) Reports Q1 Loss, Lags Revenue Estimates
AXGN

Zacks

a year ago

AxoGen (AXGN) Reports Q1 Loss, Lags Revenue Estimates

AXGN

Associated Press Finance

a year ago

AxoGen: Q1 Earnings Snapshot

Axogen, Inc Reports First Quarter 2024 Financial Results
AXGN

GlobeNewswire

a year ago

Axogen, Inc Reports First Quarter 2024 Financial Results

AxoGen, Inc. (NASDAQ:AXGN) is largely controlled by institutional shareholders who own 58% of the company
AXGN

Simply Wall St.

a year ago

AxoGen, Inc. (NASDAQ:AXGN) is largely controlled by institutional shareholders who own 58% of the company

Axogen Announces First Surgical Implants of Avive+ Soft Tissue Matrix™
AXGN

GlobeNewswire

a year ago

Axogen Announces First Surgical Implants of Avive+ Soft Tissue Matrix™

Axogen, Inc. to Report First Quarter 2024 Financial Results and Host Conference Call on May 2, 2024
AXGN

GlobeNewswire

a year ago

Axogen, Inc. to Report First Quarter 2024 Financial Results and Host Conference Call on May 2, 2024

Analysts Expect Breakeven For AxoGen, Inc. (NASDAQ:AXGN) Before Long
AXGN

Simply Wall St.

a year ago

Analysts Expect Breakeven For AxoGen, Inc. (NASDAQ:AXGN) Before Long

Director Gregory Freitag Sells 25,000 Shares of Axogen Inc (AXGN)
AXGN

GuruFocus.com

a year ago

Director Gregory Freitag Sells 25,000 Shares of Axogen Inc (AXGN)

US$13.80 - That's What Analysts Think AxoGen, Inc. (NASDAQ:AXGN) Is Worth After These Results
AXGN

Simply Wall St.

a year ago

US$13.80 - That's What Analysts Think AxoGen, Inc. (NASDAQ:AXGN) Is Worth After These Results

AxoGen, Inc. (NASDAQ:AXGN) Q4 2023 Earnings Call Transcript
AXGN

Insider Monkey

a year ago

AxoGen, Inc. (NASDAQ:AXGN) Q4 2023 Earnings Call Transcript

AxoGen Full Year 2023 Earnings: Beats Expectations
AXGN

Simply Wall St.

a year ago

AxoGen Full Year 2023 Earnings: Beats Expectations

AXGN

Thomson Reuters StreetEvents

a year ago

Q4 2023 AxoGen Inc Earnings Call

AXGN

Associated Press Finance

a year ago

AxoGen: Q4 Earnings Snapshot

Axogen Inc (AXGN) Reports Growth in Revenue and Reduction in Net Loss for Q4 and Full-Year 2023
AXGN

GuruFocus.com

a year ago

Axogen Inc (AXGN) Reports Growth in Revenue and Reduction in Net Loss for Q4 and Full-Year 2023

Axogen, Inc Reports 2023 Fourth Quarter and Full-Year Financial Results
AXGN

GlobeNewswire

a year ago

Axogen, Inc Reports 2023 Fourth Quarter and Full-Year Financial Results

Zacks.com featured highlights Protagonist Therapeutics, AxoGen, Western Digital and Phunware
AXGN

Zacks

a year ago

Zacks.com featured highlights Protagonist Therapeutics, AxoGen, Western Digital and Phunware

Ekso Bionics (EKSO) Reports Q4 Loss, Tops Revenue Estimates
AXGN

Zacks

a year ago

Ekso Bionics (EKSO) Reports Q4 Loss, Tops Revenue Estimates

AxoGen (AXGN) Is a Great Choice for 'Trend' Investors, Here's Why
AXGN

Zacks

a year ago

AxoGen (AXGN) Is a Great Choice for 'Trend' Investors, Here's Why

AxoGen, Inc. (AXGN) Hit a 52 Week High, Can the Run Continue?
AXGN

Zacks

a year ago

AxoGen, Inc. (AXGN) Hit a 52 Week High, Can the Run Continue?

Zacks.com featured highlights AxoGen, Western Digital and Gen Digital
AXGN

Zacks

a year ago

Zacks.com featured highlights AxoGen, Western Digital and Gen Digital

3 Best Stocks to Buy for Remarkable Earnings Acceleration
AXGN

Zacks

a year ago

3 Best Stocks to Buy for Remarkable Earnings Acceleration

Axogen, Inc. to Report 2023 Fourth Quarter and Full-Year Financial Results on March 5, 2024
AXGN

GlobeNewswire

a year ago

Axogen, Inc. to Report 2023 Fourth Quarter and Full-Year Financial Results on March 5, 2024

Share on Social Networks: